PLASMODIUM FALCIPARUM INFECTION
Clinical trials for PLASMODIUM FALCIPARUM INFECTION explained in plain language.
Never miss a new study
Get alerted when new PLASMODIUM FALCIPARUM INFECTION trials appear
Sign up with your email to follow new studies for PLASMODIUM FALCIPARUM INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Shot antibody shows promise against malaria in kids
Prevention CompletedThis study tested a single injection of a lab-made antibody called L9LS in healthy Kenyan children aged 5 months to 10 years. The goal was to see if it is safe and can protect against malaria caused by the Plasmodium falciparum parasite. Over 900 children took part, and researche…
Matched conditions: PLASMODIUM FALCIPARUM INFECTION
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Prevention
Last updated May 18, 2026 11:59 UTC
-
Malaria drug study aims to save more Children's lives
Knowledge-focused CompletedThis study looked at how the body processes IV artesunate in children with severe malaria. About 90 Ugandan children aged 6 months to 14 years received standard doses of the drug. Researchers measured changes in vital signs and lab values to better understand how the drug works a…
Matched conditions: PLASMODIUM FALCIPARUM INFECTION
Phase: PHASE4 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC